Moody Aldrich Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-26,180
| Closed | -$2.98M | – | 188 |
|
|
2021
Q1 | $2.98M | Buy |
26,180
+448
| +2% | +$51K | 0.43% | 79 |
|
|
2020
Q4 | $3.56M | Buy |
25,732
+60
| +0.2% | +$8.31K | 0.57% | 78 |
|
|
2020
Q3 | $2.11M | Buy |
+25,672
| New | +$2.11M | 0.44% | 88 |
|
|
2017
Q1 | – | Sell |
-9,665
| Closed | -$680K | – | 96 |
|
|
2016
Q4 | $680K | Buy |
9,665
+5,135
| +113% | +$361K | 0.44% | 82 |
|
|
2016
Q3 | $321K | Buy |
+4,530
| New | +$321K | 0.22% | 92 |
|